Collateral metabolic vulnerabilities unveiled by loss of isozyme diversity in breast cancer
Rui Ding, Tian-Jian Yu, Yi-Zhou Jiang, Yi Xiao, Zhi-Ming Shao · 2025
Read Collateral metabolic vulnerabilities unveiled by loss of isozyme diversity in breast cancer by Rui Ding, Tian-Jian Yu, Yi-Zhou Jiang, Yi Xiao, Zhi-Ming Shao (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12817777.txt.
Description
Rui Ding and colleagues mapped a metabolic weakness in breast cancer in 2025. Cancer cells often keep backup enzyme versions. Losing backup versions creates single-enzyme dependence. That dependence can become a drug target. Large breast cancer datasets were integrated.
Patterns covered all breast cancer subtypes. One clear weakness involved a transferase enzyme. Blocking its partner enzyme hurt those tumours. The effect may run through a growth protein. That protein needs a fat modification step. Inhibitor drugs already exist for testing. The authors frame a precision strategy. Multi-omics data made the mapping possible.
Catalog record
| CREATOR | Rui Ding, Tian-Jian Yu, Yi-Zhou Jiang, Yi Xiao, Zhi-Ming Shao |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 78 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |